Nanobiotix S.A Cash Flow-to-Debt Ratio
Nanobiotix S.A cash flow-to-debt ratio. Nanobiotix S.A (NANO) has a Cash Flow-to-Debt Ratio of -0.15x as of June 2025, meaning its operating cash flow of €-17.41 Million could theoretically repay 0% of its total liabilities (€114.13 Million) in one year. Check Nanobiotix S.A investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nanobiotix S.A (2011–2024)
Cash flow-to-debt ratio of Nanobiotix S.A from 2011 to 2024. Historical debt coverage capacity for Nanobiotix S.A across 14 annual periods. See debt-free asset ratio of Nanobiotix S.A to measure how much of total assets are equity-financed.
Nanobiotix S.A Cash Flow-to-Debt Ratio by Year (2011–2024)
Nanobiotix S.A cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Nanobiotix S.A. For the full cash flow conversion analysis, see NANO cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | €-19.55 Million | €133.12 Million | ▼ -12.7% |
| 2023 | -0.13x | €-12.48 Million | €95.74 Million | ▲ +69.5% |
| 2022 | -0.43x | €-37.10 Million | €86.81 Million | ▼ -3.4% |
| 2021 | -0.41x | €-31.00 Million | €74.98 Million | ▲ +6.9% |
| 2020 | -0.44x | €-28.24 Million | €63.56 Million | ▲ +37.8% |
| 2019 | -0.71x | €-41.52 Million | €58.11 Million | ▲ +12.1% |
| 2018 | -0.81x | €-25.98 Million | €31.95 Million | ▲ +47.4% |
| 2017 | -1.55x | €-20.95 Million | €13.54 Million | ▼ -10.0% |
| 2016 | -1.41x | €-18.28 Million | €13.00 Million | ▲ +9.7% |
| 2015 | -1.56x | €-16.82 Million | €10.81 Million | ▼ -22.5% |
| 2014 | -1.27x | €-8.56 Million | €6.74 Million | ▲ +20.8% |
| 2013 | -1.60x | €-6.83 Million | €4.26 Million | ▼ -41.0% |
| 2012 | -1.14x | €-3.79 Million | €3.33 Million | ▲ +53.6% |
| 2011 | -2.45x | €-4.87 Million | €1.99 Million | — |